Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-23-000035

Chief Financial Officer acquired 26,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
White Lauren Chief Financial Officer 2023-02-13 Grant or award +26,000 31,097 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
White Lauren Chief Financial Officer 2023-02-13 Grant or award · Stock Option (Right to Buy) +125,000 125,000 D: show line 2 in the form
Loading xslF345X03/wf-form4_167649747523081.xml…